EUVIMEDEUVIMED entdecken
Crossref

AMPICILLIN SULBACTAM RESISTANCE PATTERN AS A FIRST-LINE DRUG IN CHILDREN

Oka Putrawan, IGAA Putri Sri Rejeki

Folia Medica Indonesiana · 2016

DOI: 10.20473/fmi.v51i3.2834 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Folia Medica Indonesiana, 2016. Verfasst von Oka Putrawan und 1 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 7 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Infection often occurs in children with malignant hematology and causes morbidity and mortality. Antibiotics should be given based on the results of culture and antibiotic susceptibility test. Ampicillin Sulbactam is a first-line drug in children with infection. The purpose of this study was to obtain an objective overview of Ampicillin Sulbactam resistance patterns of culture in patients hospitalized in pediatric Hemato-Oncology Ward, Dr Soetomo Hospital, Surabaya. This was a descriptive study. Data on culture and susceptibility test result to Ampicillin Sulbactam were taken from medical records of those patients between September 2012 - February 2013. There were 342 culture examinations in 88 patients (44 girls and 44 boys). Most of the children aged

Zitieren

APA

Putrawan, O., & Rejeki, I. P. S. (2016). AMPICILLIN SULBACTAM RESISTANCE PATTERN AS A FIRST-LINE DRUG IN CHILDREN. Folia Medica Indonesiana. https://doi.org/10.20473/fmi.v51i3.2834

Vancouver

Putrawan O, Rejeki IPS. AMPICILLIN SULBACTAM RESISTANCE PATTERN AS A FIRST-LINE DRUG IN CHILDREN. Folia Medica Indonesiana. 2016. doi:10.20473/fmi.v51i3.2834

BibTeX
@article{Putrawan2016,
  author = {Putrawan, Oka and Rejeki, IGAA Putri Sri},
  title = {AMPICILLIN SULBACTAM RESISTANCE PATTERN AS A FIRST-LINE DRUG IN CHILDREN},
  journal = {Folia Medica Indonesiana},
  year = {2016},
  doi = {10.20473/fmi.v51i3.2834}
}
Kostenlos starten →